Stock price when the opinion was issued
(A Top Pick Aug 18/15. Down 6.82%.) The space overall is great and the company is great, and he still thinks it is a very attractive name. Healthcare started to sell off in the late fall. A lot of these things are collateral damage from the Valeant fall out. It is still a good name and is something he is looking at and would like to enter.
This basically operates 2 divisions. Behavioural, where they do things like drug addiction facilities, and acute care. Both are growing very strongly, particularly the behavioural side which is 70% of their business. It has higher margins and higher growth. They are also beneficiaries of Obama care.